Sector Vertex Pharmaceuticals Incorporated

Aandelen

VRTX

US92532F1003

Farmaceutische producten

Beurs gesloten - 22:00:00 02-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
504,73 USD -0,40% Intraday-grafiek van Vertex Pharmaceuticals Incorporated -4,08% +11,33%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-0,40%-4,08%-9,54%-4,41%+11,33%+25,15%+46,23%+179,86%+481,55% 128 mld.
-0,61%-3,43%-1,44%-5,85%+6,34%+36,07%+117,61%+397,78%+1.310,93% 1.019 mld.
-1,02%-5,60%-8,05%-2,66%+23,72%+35,72%+64,82%+59,55%+115,50% 617 mld.
+1,11%-0,58%+1,00%+0,67%+15,02%+12,36%+78,27%+140,92%+315,66% 464 mld.
+0,34%-3,01%-5,28%+11,38%+37,09%+61,79%+41,79%+77,27%+130,81% 356 mld.
-0,95%-4,05%-3,03%+1,50%+5,33%+20,54%+40,33%+0,13%+43,03% 333 mld.
-1,46%-2,89%-11,41%-9,05%+6,15%+10,57%+26,54%+52,96%+51,29% 267 mld.
-1,35%-5,43%-2,27%-17,89%-13,92%-6,17%+8,82%+35,30%+135,47% 244 mld.
-1,04%-2,79%-9,25%+7,72%+23,14%+35,30%+54,42%+88,41%+140,85% 218 mld.
-1,87%-4,10%-4,29%+10,26%+17,92%+28,44%+97,54%+111,11%+85,49% 179 mld.
-0,50%-1,68%-17,51%-23,91%-23,52%-34,34%-60,24%-18,84%+83,24% 166 mld.
-1,14%-3,03%-3,51%+14,31%+11,65%+1,57%-17,99%-35,24%-17,46% 158 mld.
+0,53%-2,72%-10,19%+5,20%+13,37%+34,54%+6,87%+2,76%+11,87% 125 mld.
+0,38%+4,11%-2,07%+14,75%+10,00%+22,25%+105,77%+351,09%+445,58% 105 mld.
-3,13%-1,37%-7,16%-6,60%-14,40%-18,42%-30,28%-14,28%+3,77% 95,48 mld.
-0,86%-3,86%-4,66%-11,69%-2,47%+9,27%+19,82%+2,74%-14,50% 94,34 mld.
+0,57%-4,46%+27,63%+138,23%+544,32%+566,94%+84,33%-44,29% - 75,86 mld.
+0,05%-6,71%-12,84%+12,37%-4,75%+22,53%-9,04%+28,80%+82,51% 73,41 mld.
+1,82%+1,41%-0,69%-6,01%+11,66%+13,28%-11,22%-25,19%+42,74% 66,99 mld.
-2,32%-8,83%-12,30%-21,07%-26,82%-13,57%+34,01%+46,91%+394,43% 62,92 mld.
Gemiddelde -0,59%-2,99%-4,84%+5,36%+32,56%+43,19%+34,92%+71,89%+202,25% 242,42 mld.
Gewogen gemiddelde per kap. -0,57%-3,08%-4,58%+0,39%+18,59%+32,12%+56,56%+133,52%+389,86%
  1. Beurs
  2. Aandelen
  3. Koers VRTX
  4. Sector Vertex Pharmaceuticals Incorporated